Full Text View
Tabular View
No Study Results Posted
Related Studies
An Open-Label Evaluation of the Dose Proportionality of OROS� Hydromorphone HCL Tablets 8mg, 16mg, 32mg, 64mg
This study has been completed.
Study NCT00398957   Information provided by Alza Corporation, DE, USA

First Received on November 10, 2006.   Last Updated on April 26, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Analgesia
Additional drug interventions recognized in this trial
Analgesics, Opioid
Hydromorphone
Naltrexone
Narcotic Antagonists
More general drug interventions related to this trial
Analgesics
Central Nervous System Agents
Central Nervous System Depressants
Narcotics
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Alza Corporation, DE, USA


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services